INS and Hypoglycemia: Rosenstock et al. [29] demonstrated in the BRIGHT study that Gla-300 and IDeg-100 have similar glycemic control, hypoglycemia incidence and rates were comparable with both insulins during the full study period but lower in favor of Gla-300 during the titration period.